News
Home/ News
(Filtering posts by category: Patents) - Remove filter
For years, Australian innovators have faced uncertainty over whether computer-implemented inventions — software-based systems, digital platforms, or automated processes — can actually be patented. Now, a new Full Court decision has finally brought some clarity — and good news for software and technology businesses.
In a recent decision, Jackman J of the Federal Court handed down a detailed ruling in Abbey Laboratories Pty Ltd v Virbac (Australia) Pty Ltd (No 3) — a case that dives deep into the complexities of inventive step, novelty, and patent validity in the veterinary pharmaceutical field.
Australia and New Zealand share a common legal heritage — both tracing their patent systems back to the Statute of Monopolies (1623) — but over time, the two jurisdictions have taken different paths. For innovators filing in both countries, understanding these differences can mean the difference between smooth prosecution and costly delays.
Australia’s patent landscape is evolving — and not always in ways that make life easier for innovators. A recent legal trend known as the “relevant range” concept has begun to reshape how courts assess whether a patent specification is sufficiently enabling.
New Zealand’s rules around genetically modified organisms (GMOs) are set for a major update. Find out what this means for innovators and the different rules that apply to different countries.
In patent law, a brilliant invention is only half the battle. The other half is proving—on paper—who owns it. A missing signature or unclear transfer can destroy the value of an entire patent portfolio.
In a ruling that could reshape India’s heart drug market, the Indian Patent Office has revoked Novartis’ patent for its blockbuster therapy Vymada (sold internationally as Entresto). The decision, issued on September 12, found that Novartis’ claims lacked novelty, inventive step, and sufficient proof of enhanced efficacy.
Australia remains one of the few jurisdictions that requires a patent applicant to disclose the “best method” of carrying out an invention. This requirement is strictly enforced — and in recent years, it has become a powerful ground for revoking patents, particularly in the context of divisional applications.
Indonesia isn’t just our closest neighbour — it’s ASEAN’s largest economy, home to more than 270 million people, and one of the fastest-transforming markets in the world. Indonesia’s rise offers an unprecedented opportunity for Australian businesses.
